Abstract. We previously reported that endothelium-derived hyperpolarizing factor (EDHF)-mediated response time-dependently suppressed methoxamine-induced vasoconstriction in mesenteric vascular beds isolated from 8-week-old rats. We investigated age-related changes in endothelial regulation of methoxamine-induced vasoconstriction. Mesenteric vascular beds isolated from young (8-week-old) to adult (16-week-old) rats were perfused, and changes in perfusion pressure induced by continuous perfusion of methoxamine or high KCl (60 mM) were measured over 180 min. In young preparations with intact endothelium, methoxamine-induced vasoconstriction time-dependently decreased to 20% of the initial levels, while time-dependent reduction was not observed in adult preparations. High KCl-induced vasoconstriction in young and adult preparations did not show time-dependent reduction. Endothelium removal abolished time-dependent reduction of methoxamine-induced vasoconstriction in young preparations and significantly attenuated vasoconstriction in adult preparations. Indomethacin, seratrodast, or tempol but not catalase significantly reduced methoxamine-induced vasoconstriction in adult preparations with endothelium. A23187 (Ca
Introduction
The functional deficiency of the endothelium associated with aging has been reported in blood vessels (1 -4) . The reduction of acetylcholine-induced endotheliumdependent relaxation has been found in different blood vessels from old animals, implying that the ability of the endothelium to dilate blood vessels in response to agonists or physical stimuli decreases with aging (1 -4) . Furthermore, the endothelium-dependent inhibition of vasoconstrictor responses to α-adrenoceptor agonists, adrenergic transmitter noradrenaline, 5-hydroxytryptamine, and endothelin-1 in resistance arteries and the aorta has also been reported to decrease with aging (3, 5 -8) . It is therefore possible that age-related dysfunction of the endothelium is due to a decrease in produc-tion of endothelium-derived relaxing factors (EDRF) and/or an increase in the production of endotheliumderived contracting factors (EDCF) (9) . It has been reported that aging or pathological conditions (e.g., spontaneous hypertension and diabetes) augments the release of EDCFs (10 -13) . Additionally, several studies reported that the aged blood vessel wall is characterized by the increased production of cyclooxygenase (COX)-derived EDCF such as thromboxane A 2 (TXA 2 ) or prostaglandin F 2α (PGF 2α ) (12) . Furthermore, age-related endothelium dysfunction has been reported to involve increased oxidative stress (14, 15) . However, the mechanism underlying age-related endothelial dysfunction in peripheral resistance arteries remains unclear. Our recent study demonstrated that the endothelium in mesenteric resistance arteries inhibits α 1 -adrenoceptor agonist (methoxamine)-induced vasoconstriction by the endothelium-derived hyperpolarizing factor (EDHF)-mediated response (16) . Therefore, this study was designed to investigate age-related changes in endothelial regulation of vasoconstriction induced by continuous perfusion of methoxamine (selective α 1 -adrenoceptor agonist) or a Krebs solution containing high K + (high KCl) in rat mesenteric vascular beds isolated from young (8-week-old) to adult (16-week-old) rats. Furthermore, to clarify the possible involvement of EDCF and reactive oxygen species (ROS) in age-related changes in methoxamine-induced vasoconstriction in preparations from 16-week-old rats, the effects of endothelium removal, indomethacin (COX inhibitor), seratrodast (TXA 2 -receptor antagonist), tempol [superoxide dismutase (SOD) mimetic], and catalase (antioxidant enzyme degrading hydrogen peroxide) were also examined.
Materials and Methods

Animals
Male Wistar rats weighing 250 -450 g (8-to 16-week-old) were used in this study. The animals were given food and water ad libitum. They were housed in the Animal Research Center of Okayama University at a controlled ambient temperature of 22 ± 2°C with 50 ± 10% relative humidity and a 12-h light / 12-h dark cycle (lights on 08:00 AM). This study was carried out in accordance with the Guidelines for Animal Experiments at Okayama University Advanced Science Research Center, Japanese Government Animal Protection and Management Law (No. 105), and Japanese Government Notification on Feeding and Safekeeping of Animals (No. 6). Every effort was made to minimize the number of animals used and suffering.
Perfusion of the mesenteric vascular bed
The animals were anesthetized with pentobarbital-Na (50 mg/kg, i.p.), and the mesenteric vascular beds were isolated and prepared for perfusion as described previously (17, 18) . The isolated mesenteric vascular bed was placed in a water-jacketed organ bath maintained at 37°C and perfused with a Krebs solution at a constant flow rate of 5 ml/min with a peristaltic pump (model AC-2120; ATTO Co., Tokyo). Preparations were also superfused with the same solution at a rate of 0.5 ml/min to prevent drying. The Krebs solution was bubbled with a mixture of 95% O 2 -5% CO 2 before passage through a warming coil maintained at 37°C. Modified Krebs solution was of the following composition: 119.0 mM NaCl, 4.7 mM KCl, 2.4 mM CaCl 2 , 1.2 mM MgSO 4 , 25.0 mM NaHCO 3 , 1.2 mM KH 2 PO 4 , 0.03 mM disodium ethylenediaminetetraacetic acid, and 11.1 mM dextrose (pH 7.4). A high KCl solution was prepared by equimolar replacement of NaCl. Changes in the perfusion pressure were measured with a pressure transducer (model TP-400T; Nihon Kohden, Tokyo) and recorded using a pen recorder (model U-228; Nippon Denshi Kagaku, Tokyo).
Chemical removal of the vascular endothelium
To remove the vascular endothelium, preparations with resting tone were perfused with 1.80 mg/ ml of sodium deoxycholate in saline for 30 s to remove the vascular endothelium, as described previously (19, 20) . This caused a transient increase (20 to 30 mmHg) in perfusion pressure. Then, the preparations were rinsed with sodium deoxycholate-free Krebs solution for 60 min and subjected to perfusion with various agents. After the preparation was contracted by perfusion with Krebs solution containing methoxamine (2 μM), successful removal of the endothelium was assessed by the lack of a relaxant effect to a bolus injection of 1 nmol acetylcholine, which was injected directly into the perfusate proximal to the arterial cannula by an infusion pump (model 975; Harvard Apparatus, S Natick, MA, USA). Volumes were 100 μl over 12 s.
Bolus injection of acetylcholine and A23187
After equilibration for 30 min, the preparation was perfused with Krebs solution containing methoxamine (7 μM) to induce submaximal contraction. After stabilization of the elevated perfusion pressure, acetylcholine (muscarinic acetylcholine-receptor agonist, 1 nmol) and A23187 (Ca
2+
-ionophore, 10 μmol) were infused directly into the perfusate proximal to the arterial cannula with an injection pump. Injection volumes were 100 μl over 12 s.
Experimental protocols
After the basal perfusion pressure had stabilized, each preparation with or without the endothelium was perfused with Krebs solution containing methoxamine (2 -7 μM) or high KCl medium (60 mM) to induce an increase in perfusion pressure due to vasoconstriction, and changes in perfusion pressure were observed for over 180 min.
To assess the underlying mechanisms, changes in perfusion pressure induced by methoxamine and high KCl were observed in preparations without endothelium. In the experiment using endothelium-denuded preparations, the concentration of methoxamine was reduced to 2 μM, which induced an increase in perfusion pressure to a similar level to that in preparations with an intact endothelium, since endothelium removal enhanced the vasoconstrictor response to methoxamine (16, 21) .
To assess involvement of COX-derived EDCF, TXA 2 or ROS, after the basal perfusion pressure had stabilized, combined perfusion of Krebs solution containing 7 μM methoxamine and indomethacin (1 μM), seratrodast (1 μM), tempol (100 μM), or catalase (1000 U /ml) were examined in preparations with an intact endothelium from 16-week-old rats.
In another series of experiments, the vasodilator responses to a bolus injection of acetylcholine and A23187 were examined in preparations with the endothelium from 8-and 16-week-old rats. After equilibration, each preparation was perfused with Krebs solution containing methoxamine or methoxamine plus N G -Lnitro arginine methyl ether [nitric oxide (NO) synthase inhibitor; L-NAME, 100 μM]. After stabilization of the elevated perfusion pressure, acetylcholine (1 nmol) or A23187 (10 μmol) diluted with Krebs solution containing methoxamine or methoxamine plus L-NAME were directly infused into the perfusate proximal to the arterial cannula with an infusion pump.
At the end of each experiment, 100 μM papaverine was perfused to produce complete vasodilation. The maximum increase in perfusion pressure induced by methoxamine and high KCl was taken as the maximum vasoconstrictor response, which was set as time 0, and the time-dependent changes in perfusion pressure were observed for 180 min and expressed as a percent of the maximum vasoconstriction (peak amplitude). Values of the area under the curve of increase in mean perfusion pressure (AUC iMPP ) were calculated using MOMENT (EXCEL). Vasodilation induced by acetylcholine or A23187 was expressed as a percent of the perfusion pressure at maximum relaxation induced by 100 μM papaverine.
Statistical analyses
Data are shown as the mean ± S.E.M. Statistical analysis was performed by the Student's t-test for unpaired observations between two groups and one-way analysis of variance followed by Tukey's test for multiple comparisons. P<0.05 was considered statistically significant.
Drugs
The following drugs were used in this study:
benzoxazole-4-carboxylic acid}, catalase, indomethacin, and tempol (4-hydroxy-2,2,6,6-tetramethyl piperidine-N-oxyl) (Sigma Aldrich Japan, Tokyo); acetylcholine chloride (Daiichi-Sankyo Pharmaceutical Co., Tokyo); methoxamine hydrochloride (Nihon Shinyaku, Kyoto); papaverine hydrochloride (Dainippon-Sumitomo Pharmaceutical Co., Osaka); seratrodast (Takeda Chemical Industries Ltd., Osaka); and sodium deoxycholate (Ishizu Seiyaku Co., Tokyo). Sodium deoxycholate was dissolved in 0.9% saline. Indomethacin or seratrodast was dissolved in 50% ethanol and diluted with Krebs solution. All other drugs were dissolved in distilled water and diluted with Krebs solution containing 7 μM methoxamine when perfused or injected directly.
Results
Food intake, body weight, systolic blood pressure, and heart rate Body weight of 16-week-old rats (422.3 ± 6.8 g) was significantly greater than that of 8-week-old rats (251.0 ± 1.0 g) (P<0.01, n = 6 in each group). There were no significant changes in daily food intake between 8-week-old rats (25.8 ± 1.9 g/ day, n = 6) and 16-weekold rats (22.3 ± 1.0 g/ day, n = 6). The systolic blood pressure in 16-week-old rats (139.4 ± 6.9 mmHg) was significantly higher than that in 8-week-old rats (119.2 ± 5.0 mmHg) (P<0.01, n = 6 in each group). There was no significant difference in heart rate between 8-and 16-week-old rats (422.0 ± 12.5 beats/min vs. 438.0 ± 22.5 beats /min, n = 6 in each group).
Age-related changes in vasoconstriction induced by continuous perfusion of methoxamine
As shown in Fig. 1 , in mesenteric preparations, continuous perfusion of 7 μM methoxamine for 180 min induced an initial sharp increase in perfusion pressure due to phasic vasoconstriction followed by a longlasting increase in perfusion pressure due to tonic vasoconstriction. During 180-min perfusion, in preparations with intact endothelium isolated from 8-week-old rats, the tonic vasoconstriction gradually decreased to reach 20% of the initial levels in a time-dependent manner ( Fig. 1: A and C) . In contrast, in preparations from 16-week-old rats (Fig. 1B) , the tonic vasoconstriction induced by methoxamine was maintained over 180 min throughout the experiment, gradually increasing, with no time-dependent reduction observed (Fig. 1C) . The area under the curve of the methoxamine (7 μM)-induced increase in mean perfusion pressure (AUC iMPP ) in 16-week-old preparations was approximately 2-fold greater than that in 8-week-old preparations ( Table 1) . As shown in Fig. 1C , time-dependent reduction of vasoconstriction induced by continuous perfusion of methoxamine was not observed in mesenteric vascular beds isolated from 10-, 12-, and 16-week-old preparations. There were significant differences in vasoconstriction at 180 min between 8-week-old preparations and 10-, 12-, or 16-week-old preparations (8-week-old, 13.8 ± 2.9%; 10-week-old, 82.1 ± 14.1%*; 12-week-old, 97.5 ± 7.6%*; 16-week-old, 135.7 ± 12.5%*; *P<0.01, compared with 8-week-old; n = 6 in each group).
Age-related changes in vasoconstriction induced by continuous perfusion of high KCl
Perfusion of Krebs solution with high KCl (60 mM) in 8-week-old preparations with intact endothelium induced vasoconstriction, which produced perfusion pressure increases similar to methoxamine at a concentration of 7 μM (high KCl, 114.2 ± 4.5 mmHg; methoxamine, 117.8 ± 7.2 mmHg; n = 6 in each group). The initial levels of increased perfusion pressure induced by perfusion of high KCl were maintained over 180 min throughout the experiment, whereas time-dependent reduction was not observed in preparations from 8-and 16-week-old rats, as shown Fig. 2, A and B . There was no significant difference in AUC iMPP of high KClinduced vasoconstriction between preparations from 8-and 16-week-old preparations (Fig. 2C and Table 1 ).
Effect of endothelium removal on vasoconstriction induced by methoxamine in preparations from 8-and 16-week-old rats Vasoconstriction induced by methoxamine was aug- mented by chemical removal of the vascular endothelium in 8-week-old preparations. In 8-week-old preparations without an endothelium, the time-dependent reduction in methoxamine-induced vasoconstriction was significantly attenuated as shown in Fig. 3 , A and C. However, in 16-week-old preparations without endothelium, the gradual increase in tonic phase vasoconstriction observed in preparations with intact endothelium disappeared and instead the tonic phase vasoconstriction was significantly decreased to levels of the vasoconstriction in denuded preparations from 8-week-old rats (Fig. 3: B and C) , as seen in our previous study (16) . There was no significant difference in AUC iMPP of methoxamine-induced vasoconstriction between preparations without endothelium from 8-and 16-week-old rats (Fig. 3C and Table 1 ).
Effect of indomethacin, seratrodast, tempol, and catalase on vasoconstriction induced by methoxamine in preparations from 16-week-old rats As shown in Fig. 4 , in 16-week-old preparations with intact endothelium, combined perfusion of indomethacin (COX inhibitor, 1 μM) or seratrodast (TXA 2 -receptor antagonist, 1 μM) significantly reduced tonic vasoconstriction induced by continuous perfusion of 7 μM methoxamine. However, time-dependent reduction in vasoconstriction was not observed. Furthermore, tempol (SOD mimetic, 100 μM), but not catalase (antioxidant enzyme degrading hydrogen peroxide, 1000 U /ml), also significantly suppressed the gradual increase in methoxamine-induced vasoconstriction (Fig. 4) . 
Vasodilator responses to acetylcholine and A23187 in preparations from 8-and 16-week-old rats
In preparations with intact endothelium and active tone produced by methoxamine, a bolus injection of acetylcholine (1 nmol) or A23187 (Ca
2+
-ionophore, 10 μmol) produced a sharp and transient decrease in perfusion pressure due to vasodilation (Fig. 5A) . The acetylcholine-and A23187-induced vasodilations were not affected by L-NAME (NO synthase inhibitor) (Fig. 5C ) and were abolished by endothelium removal (Fig. 5 : B and C). As shown in Fig. 5C , there was no significant difference in the vasodilation induced by acetylcholine and A23187 between 8-week-old and 16-week-old preparations. However, vasodilation induced by A23187, but not acetylcholine, in the presence of 100 μM L-NAME in 16-week-old preparations was significantly smaller than that in 8-week-old preparations.
Discussion
The present and our previous study (16) demonstrated that the tonic phase of vasoconstriction induced by continuous perfusion of a selective α 1 -adrenoceptor agonist, methoxamine, in the rat mesenteric vascular bed with intact endothelium isolated from 8-week-old rats was not maintained and gradually decreased over 180-min perfusion, causing a time-dependent reduction in methoxamine-induced vasoconstriction. However, the present study demonstrated that the tonic phase of methoxamine-induced vasoconstriction in preparations from 16-week-old rats was maintained for 180 min throughout the perfusion and time-dependent reduction in methoxamine-induced vasoconstriction did not occur, suggesting that the time-dependent reduction in tonic vasoconstriction induced by methoxamine markedly decreases and/ or disappears with aging. Furthermore, a detailed investigation about age-related changes showed that disappearance of time-dependent reduction occurred in preparations from rats over 10-week-old. However, vasoconstriction induced by Krebs solution containing high K + -medium in preparations from 8-week-old rats was maintained over 180 min and was not affected by aging. Therefore, it is unlikely that the time-dependent reduction in methoxamine-induced tonic vasoconstriction in 8-week-old preparations is due to decreased constrictive activity of arterial smooth muscles. Some studies have shown no age-dependent changes in the density of α 1 -adrenoceptors (22, 23) . Furthermore, high KCl-induced vasoconstriction was not altered with aging, suggesting that membrane depolarization-induced smooth muscle contractility is not responsible for the age-related disappearance of the time-dependent reduction in methoxamine-induced vasoconstriction.
Age-related alterations in the vasoconstrictor response to various stimuli including α-adrenoceptor agonists and endogenous and exogenous vasoconstrictor substances (3, 5 -7), 5-hydroxytryptamine (8) and endothelin-1 (7) have been shown in rat blood vessels, suggesting that endothelium regulation of vasoconstriction alters with aging. The findings of the present and previous studies (16) that endothelium removal in 8-week-old preparations abolished the time-dependent reduction in methoxamine-induced vasoconstriction suggest that the endothelium in mesenteric resistance arteries acts to depress methoxamine-induced tonic phase vasoconstriction. Moreover, the time-dependent reduction in 8-week-old preparations did not occur in high KCl-induced vasoconstriction. The previous findings showed that the time-dependent reduction in methoxamine-induced vasoconstriction in 8-week-old preparations was inhibited in the presence of EDHF inhibitors including K + -channel inhibitors (tetraethylammonium, apamin plus charybdotoxin, 30 mM KCl) and 18α-glycyrrhetinic acid (gap-junction inhibitor), but not a NO synthase inhibitor (L-NAME) or prostanoid synthase COX inhibitor (indomethacin). Furthermore, high KCl-induced vasoconstriction in young preparations (8-week-old rats) did not show the time-dependent reduction because high concentration of KCl may suppress the relaxing effect of EDHF.
Taken together, it is very likely that the EDHFmediated response is responsible for the time-dependent reduction in methoxamine-induced vasoconstriction in preparations from 8-week-old rats. Therefore, the disappearance of time-dependent reduction in methoxamineinduced tonic constriction in preparations from 16-weekold rats is likely to be due to the marked reduction and/or abolition of EDHF inducing K + -channel opening and activation of gap communication in the methoxamineinduced vasoconstriction in rat mesenteric resistance arteries with aging.
In the present study, methoxamine-induced tonic vasoconstriction in mesenteric vascular beds from 16-week-old rats was significantly attenuated by endothelium removal. Furthermore, in 16-week-old preparations with intact endothelium, indomethacin and seratrodast (TXA 2 receptor antagonist) also caused an equivalent reduction to endothelium removal in methoxamineinduced tonic vasoconstriction. These findings suggest that EDCF released from the endothelium contributes in part to age-related alteration of methoxamine-induced vasoconstriction in 16-week-old rats. It is likely that the endothelium-dependent inhibitory effect on methoxamine-induced vasoconstriction is dominant in young rats (8-week-old), while endothelium-dependent vasoconstriction becomes more prominent in adult rats (16-week-old) . Therefore, increased EDCF, TXA 2 , in aged vasculature probably masks the inhibitory effect of EDRF on vasoconstriction induced by various stimuli.
Oxidative stress is identified as an important factor in age-related endothelium dysfunction, which has been attributed to the increased production of ROS (14, 15) . In the present study, tempol, but not catalase, reduced methoxamine-induced tonic vasoconstriction in 16 week-old preparations, although the inhibitory effect of tempol was smaller than that of indomethacin or seratrodast. Tempol is a stable and water-soluble SOD mimetic, which scavenges superoxide anions and reduces the formation of hydroxyl radicals (24, 25) . Thus, it is likely that increased production of ROS may be in part involved in the age-related endothelium dysfunction regulating methoxamine-induced vasoconstriction, while an increase in vascular production of hydrogen peroxide is ruled out.
Many studies showed that aging reduces endotheliumdependent relaxation induced by acetylcholine (1 -4) . However, in the present study, age-related changes in acetylcholine-induced vasodilation were not observed in preparations from 8-to 16-week-old rats. It has been assumed that in the rat mesenteric circulation, as the vessel size decreases, the role of EDHF in the endothelium-dependent relaxation increases (26) . EDHF, which has been described as an endothelium-derived non-NO and non-PGI 2 factor, induces hyperpolarization of vascular smooth muscle by opening K + -channels (27 -29) in response to endothelial agonists such as acetylcholine and bradykinin and various physical stimuli. Additionally, gap junctions between endothelial cells and smooth muscle cells have been shown to be involved in EDHF-mediated relaxation (30) . In the present study, endothelium-dependent vasodilation induced by acetylcholine and A23187 in mesenteric vascular beds were not affected by L-NAME, suggesting that EDHFs mediate vasodilation. Our recent study suggested that the endothelium in mesenteric resistance arteries released different types of EDHFs in responses to methoxamine-induced vasoconstriction, acetylcholine (muscarinic receptor agonist), and A23187 (Ca
2+
-ionophore) (16) . Furthermore, we reported that gap junctions were responsible for the A23187-induced EDHFmediated response and the time-dependent reduction in methoxamine-induced vasoconstriction, whereas gap junctions do not contribute to the acetylcholine-induced EDHF-mediated response (16) . The present study showed that A23187-, but not acetylcholine-, induced EDHFmediated vasodilation in the presence of L-NAME decreased with aging. Therefore, it is possible that the endothelium-dependent inhibitory effect on agonistinduced vasoconstriction and the Ca 2+ -ionophore A23187-induced EDHF-mediated response attenuate during the early stage of aging (adulthood) before the attenuation of endothelium-dependent relaxation induced by activation of muscarinic acetylcholine receptors occurs.
In conclusion, the present results suggest that the inhibitory effect of the endothelium on methoxamineinduced vasoconstriction in mesenteric arteries markedly decreases and/or disappears with aging and that this is likely due to reduced EDHF and increased EDCF and in part ROS.
